Clinical Trial Update: HyperArc Registry Study

View source ↗

Summary

The HyperArc Registry Study sponsored by Varian (a Siemens Healthineers company) has completed, evaluating HyperArc for brain metastases and central nervous sys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Central Nervous System Neoplasm
• Intracranial Disorder

Snippet

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Brain Metastases, CNS Neoplasm | Status: COMPLETED